Concepedia

Thomas Harr

TH

Statistics

Publications

16

Citations

723

H-Index

14

Active since

1997

Affiliations

University Hospital of Geneva(Current)

University of Basel

University Hospital of Zurich

Kantonsspital Baselland

Hospital Base

Thomas Harr is an author at University Hospital of Geneva specializing in life sciences, medicine, and immunology.

Publications per year

1997–2022

16

Publications

16

Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.

Stanislaw A. Buechner, Marion Wernli, Thomas Harr et al. · Journal of Clinical Investigation · 1997 · 123 citations · Full text

, , +17

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Thomas Harr, Lars E. French · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · 2012 · 116 citations

, , +12

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients

Peter P. Sendi, Heiner C. Bucher, Thomas Harr et al. · AIDS · 1999 · 92 citations

, , +14

Green fluorescent protein as a novel tool to measure apoptosis and necrosis

Alessandro Strebel, Thomas Harr, Felix Bachmann et al. · Cytometry · 2001 · 75 citations · Full text

, , +17

High Human Herpesvirus 8 Seroprevalence in the Homosexual Population in Switzerland

Nicolas Regamey, Gieri Cathomas, Martine Schwager et al. · Journal of Clinical Microbiology · 1998 · 63 citations · Full text

, , +13

1–5 of 16